FRPRF Projected Dividend Yield

4D Pharma PLC ( OTCBB : FRPRF )

4D pharma is engaged in the development of drug ? Live Biotherapeutic products utilizing the profound impact of the gut microbiome on human health and disease. Co.'s technologies include Live Biotherapeutics, and MicroRx®. Co.'s Live Biotherapeutics are single strains of human gut-derived commensal bacteria. Co.'s drug candidates are taxonomically diverse and exhibit distinct mechanisms relevant to specific aspects of disease pathology. Co.'s MicroRx® combines techniques across microbiology, immunology and bioinformatics to characterise and interrogate its library of bacterial isolates. Co.'s library represents phylogenetic coverage of the genera of the human gut microbiome.

20 YEAR PERFORMANCE RESULTS

FRPRF Dividend History Detail
FRPRF Dividend News
FRPRF Competitors News
# of Shares: 0 Closing Price: 0.21 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor